68 Ga-DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT.
Autor: | Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman, 11941 Jordan.; School of Medicine, The University of Jordan, Amman, Jordan., Sweedat DA; Department of Nuclear Medicine, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman, 11941 Jordan., Anwer F; Department of Nuclear Medicine, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman, 11941 Jordan.; Warith International Cancer Institute, Karbala, Iraq., Istatieh F; Department of Nuclear Medicine, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman, 11941 Jordan., Juweid ME; School of Medicine, The University of Jordan, Amman, Jordan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Nuclear medicine and molecular imaging [Nucl Med Mol Imaging] 2022 Aug; Vol. 56 (4), pp. 208-210. Date of Electronic Publication: 2022 May 12. |
DOI: | 10.1007/s13139-022-00752-8 |
Abstrakt: | 68 Ga-labeled somatostatin receptor analogs physiologic distribution patterns have become recognizable among nuclear medicine physicians because of the increasing routine clinical use of this modality in the work-up of neuroendocrine tumors. Some pitfalls during 68 Ga-labeled somatostatin receptor PET/CT have recently been reported as causes of misdiagnoses. Iatrogenic microembolism as a cause of 18 F-FDG embolus is well-established; however, 68Ga-DOTATOC embolus is not well documented in the literature. In the current case, the presence and the spontaneous resolution of the 68 Ga-labeled somatostatin receptor analogs embolus during sequential PET/CT are nicely demonstrated. Awareness of this incidental finding would avoid misdiagnosis and unnecessary investigations. Competing Interests: Competing InterestsThe authors declare no competing interests. (© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2022.) |
Databáze: | MEDLINE |
Externí odkaz: |